EDURANT 25 MG TABLET

rilpivirine hydrochloride
$48.1197per EA

Strength

25 mg/1

NDC

59676027801

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

RILPIVIRINE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA202022

On Market Since

5/20/2011

Pharmacological Classes

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors

Price History

1W

0.0%

1M

+0.0%

3M

+0.0%

6M

+0.1%

1Y

+0.3%

3Y

+10.8%

5Y

+22.5%

All

+110.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.